UNIVERSITY OF FLORIDA
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1853-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.ufl.edu
Pain Modulatory Profiles in Massage for Healthy Participants
Not Applicable
Completed
- Conditions
- HealthyMusculoskeletal Pain
- Interventions
- Other: Pain Free MassageOther: ColdpressorOther: Pain Inducing Massage
- First Posted Date
- 2018-04-06
- Last Posted Date
- 2018-12-13
- Lead Sponsor
- University of Florida
- Target Recruit Count
- 60
- Registration Number
- NCT03490474
- Locations
- 🇺🇸
UF Health, Gainesville, Florida, United States
Prasugrel Versus Ticagrelor in Patients With CYP2C19 Loss-of-function: a Validation Study
- First Posted Date
- 2018-04-06
- Last Posted Date
- 2020-09-16
- Lead Sponsor
- University of Florida
- Target Recruit Count
- 14
- Registration Number
- NCT03489863
- Locations
- 🇺🇸
University of Florida, Jacksonville, Florida, United States
Incorporating Multidimensional Psychosocial Interventions Improves the Well-being of Individuals With Epilepsy
Not Applicable
Completed
- Conditions
- Seizure DisorderEpilepsy
- Interventions
- Behavioral: Medication AdherenceBehavioral: Seizure DocumentationBehavioral: Memory ImprovementBehavioral: Stress Management
- First Posted Date
- 2018-03-30
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- University of Florida
- Target Recruit Count
- 332
- Registration Number
- NCT03484039
- Locations
- 🇺🇸
UF Health Jacksonville, Jacksonville, Florida, United States
A Study of the Safety and Activity of Liposomal Irinotecan in Combination With the 5-FU and Oxaliplatin in the Preoperative Treatment of Pancreatic Adenocarcinoma
Phase 2
Active, not recruiting
- Conditions
- Pancreatic Adenocarcinoma
- Interventions
- Drug: FOLFOX regimen
- First Posted Date
- 2018-03-29
- Last Posted Date
- 2025-01-27
- Lead Sponsor
- University of Florida
- Target Recruit Count
- 45
- Registration Number
- NCT03483038
- Locations
- 🇺🇸
Orlando Health UF Health Cancer Center, Orlando, Florida, United States
🇺🇸University of Florida, Gainesville, Florida, United States
🇺🇸Tallahassee Memorial Health Care, Tallahassee, Florida, United States
Tobacco Use Treatment in Cancer Patients
Phase 4
Completed
- Conditions
- Smoking, Cigarette
- Interventions
- Other: Referral to AHEC/Quitline
- First Posted Date
- 2018-03-29
- Last Posted Date
- 2020-05-22
- Lead Sponsor
- University of Florida
- Target Recruit Count
- 90
- Registration Number
- NCT03482583
- Locations
- 🇺🇸
University of Florida, Gainesville, Florida, United States
🇺🇸UF Health Medical Oncology, Gainesville, Florida, United States
🇺🇸UF Health Radiation Oncology, Gainesville, Florida, United States
Spinal and Supra-Spinal Pain Mechanisms in Patients With Fibromyalgia
Completed
- Conditions
- FibromyalgiaPain
- Interventions
- Other: Vehicle Patch
- First Posted Date
- 2018-03-14
- Last Posted Date
- 2023-12-14
- Lead Sponsor
- University of Florida
- Target Recruit Count
- 55
- Registration Number
- NCT03464292
- Locations
- 🇺🇸
University of Florida, Gainesville, Florida, United States
Lanifibranor in Patients With Type 2 Diabetes & Nonalcoholic Fatty Liver Disease
Phase 2
Completed
- Conditions
- Nonalcoholic Fatty Liver Disease (NAFLD)Type 2 Diabetes (T2DM)
- Interventions
- Other: Placebo
- First Posted Date
- 2018-03-08
- Last Posted Date
- 2024-03-29
- Lead Sponsor
- University of Florida
- Target Recruit Count
- 128
- Registration Number
- NCT03459079
- Locations
- 🇺🇸
University of Florida, Gainesville, Florida, United States
Effects of Exenatide on Motor Function and the Brain
- First Posted Date
- 2018-03-07
- Last Posted Date
- 2022-09-16
- Lead Sponsor
- University of Florida
- Target Recruit Count
- 5
- Registration Number
- NCT03456687
- Locations
- 🇺🇸
Laboratory for Rehabilitation Neuroscience, Gainesville, Florida, United States
iCare 2: Personalized Genomic Mutation Informed Treatment of Patients With Myelodysplastic Syndromes
Not Applicable
Withdrawn
- Conditions
- Myelodysplastic Syndromes
- Interventions
- Drug: FDA-approved drug or combination of drugsDrug: FLAG inductionDevice: Computational biology simulations softwareDrug: 7 + 3 inductionOther: Supportive care alone
- First Posted Date
- 2018-02-27
- Last Posted Date
- 2019-06-11
- Lead Sponsor
- University of Florida
- Registration Number
- NCT03446638
- Locations
- 🇺🇸
University of Florida, Gainesville, Florida, United States
Low Maintenance Dose Ticagrelor Versus Clopidogrel in Diabetes Patients Undergoing PCI
Phase 4
Completed
- Conditions
- Coronary Artery DiseaseDiabetes Mellitus, Type 2
- Interventions
- First Posted Date
- 2018-02-19
- Last Posted Date
- 2021-11-30
- Lead Sponsor
- University of Florida
- Target Recruit Count
- 40
- Registration Number
- NCT03437044
- Locations
- 🇺🇸
University of Florida, Jacksonville, Florida, United States
© Copyright 2025. All Rights Reserved by MedPath